Jiangzhong Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.001x

Jiangzhong Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangzhong Pharmaceutical Co Ltd (600750) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.91 Million ≈ $-425.37K USD) by net assets (CN¥4.70 Billion ≈ $688.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangzhong Pharmaceutical Co Ltd (1998–2025)

Cash flow conversion efficiency of Jiangzhong Pharmaceutical Co Ltd from 1998 to 2025. This chart illustrates how Jiangzhong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jiangzhong Pharmaceutical Co Ltd (600750) share price today for real-time trading data and today's change.

Jiangzhong Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangzhong Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangzhong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangzhong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Jiangzhong Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Korea Gas Corporation
KO:036460
-0.081x
Energisa S.A
SA:ENGI3
-0.002x
IKD Co Ltd Class A
SHG:600933
0.052x
Buckle Inc
NYSE:BKE
0.107x
Signify N.V.
AS:LIGHT
0.106x
Chung-Hsin Electric & Machinery Mfg Corp
TW:1513
0.031x
Chenbro Micom Co Ltd
TW:8210
0.092x
CPI Europe AG
VI:CPI
0.027x

Annual Cash Flow Conversion Efficiency for Jiangzhong Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Jiangzhong Pharmaceutical Co Ltd from 1998 to 2025. Review 600750 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.70 Billion
≈ $688.21 Million
CN¥970.87 Million
≈ $142.07 Million
0.206x +17.40%
2024-12-31 CN¥4.47 Billion
≈ $654.34 Million
CN¥786.25 Million
≈ $115.05 Million
0.176x -21.44%
2023-12-31 CN¥4.63 Billion
≈ $677.30 Million
CN¥1.04 Billion
≈ $151.58 Million
0.224x -1.26%
2022-12-31 CN¥4.51 Billion
≈ $659.65 Million
CN¥1.02 Billion
≈ $149.51 Million
0.227x +13.26%
2021-12-31 CN¥4.58 Billion
≈ $670.56 Million
CN¥917.04 Million
≈ $134.19 Million
0.200x +13.06%
2020-12-31 CN¥4.25 Billion
≈ $622.10 Million
CN¥752.50 Million
≈ $110.11 Million
0.177x +8.34%
2019-12-31 CN¥3.92 Billion
≈ $574.26 Million
CN¥641.18 Million
≈ $93.82 Million
0.163x +9.32%
2018-12-31 CN¥3.25 Billion
≈ $476.08 Million
CN¥486.25 Million
≈ $71.15 Million
0.149x +248.77%
2017-12-31 CN¥2.92 Billion
≈ $426.61 Million
CN¥124.93 Million
≈ $18.28 Million
0.043x -83.94%
2016-12-31 CN¥2.62 Billion
≈ $382.77 Million
CN¥698.05 Million
≈ $102.15 Million
0.267x +23.02%
2015-12-31 CN¥2.35 Billion
≈ $344.55 Million
CN¥510.78 Million
≈ $74.74 Million
0.217x +29.69%
2014-12-31 CN¥2.13 Billion
≈ $312.15 Million
CN¥356.80 Million
≈ $52.21 Million
0.167x +218.82%
2013-12-31 CN¥2.13 Billion
≈ $312.16 Million
CN¥111.92 Million
≈ $16.38 Million
0.052x -52.42%
2012-12-31 CN¥2.05 Billion
≈ $300.43 Million
CN¥226.38 Million
≈ $33.13 Million
0.110x +25.64%
2011-12-31 CN¥1.92 Billion
≈ $280.62 Million
CN¥168.30 Million
≈ $24.63 Million
0.088x -29.76%
2010-12-31 CN¥1.78 Billion
≈ $260.34 Million
CN¥222.29 Million
≈ $32.53 Million
0.125x -64.56%
2009-12-31 CN¥1.07 Billion
≈ $157.00 Million
CN¥378.32 Million
≈ $55.36 Million
0.353x +27.13%
2008-12-31 CN¥969.41 Million
≈ $141.86 Million
CN¥268.87 Million
≈ $39.34 Million
0.277x +51.28%
2007-12-31 CN¥837.97 Million
≈ $122.62 Million
CN¥153.63 Million
≈ $22.48 Million
0.183x +148.45%
2006-12-31 CN¥748.62 Million
≈ $109.55 Million
CN¥55.24 Million
≈ $8.08 Million
0.074x -73.89%
2005-12-31 CN¥702.13 Million
≈ $102.74 Million
CN¥198.45 Million
≈ $29.04 Million
0.283x +612.79%
2004-12-31 CN¥662.81 Million
≈ $96.99 Million
CN¥26.28 Million
≈ $3.85 Million
0.040x -67.88%
2003-12-31 CN¥639.80 Million
≈ $93.62 Million
CN¥78.98 Million
≈ $11.56 Million
0.123x -25.18%
2002-12-31 CN¥575.21 Million
≈ $84.17 Million
CN¥94.90 Million
≈ $13.89 Million
0.165x +120.25%
2001-12-31 CN¥551.04 Million
≈ $80.63 Million
CN¥41.28 Million
≈ $6.04 Million
0.075x -66.43%
2000-12-31 CN¥545.76 Million
≈ $79.86 Million
CN¥121.77 Million
≈ $17.82 Million
0.223x +625.92%
1999-12-31 CN¥516.08 Million
≈ $75.52 Million
CN¥-21.89 Million
≈ $-3.20 Million
-0.042x -3.26%
1998-12-31 CN¥277.86 Million
≈ $40.66 Million
CN¥-11.42 Million
≈ $-1.67 Million
-0.041x --

About Jiangzhong Pharmaceutical Co Ltd

SHG:600750 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.16 Billion
CN¥14.75 Billion CNY
Market Cap Rank
#5682 Global
#1021 in China
Share Price
CN¥23.21
Change (1 day)
+0.00%
52-Week Range
CN¥21.46 - CN¥27.69
All Time High
CN¥561.13
About

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsu… Read more